Commure Engage

What is Commure Engage and who sells it?

Commure Engage is the product formerly known as Memora Health. The memorahealth.com address now serves the Commure Engage page, which describes the platform as powering "patient access and engagement across the care journey, from intake to call center operations to ongoing care."

Commure announced the acquisition on 20 December 2024. Axios reported an all-stock deal, while other outlets said terms were not disclosed. Commure had acquired the scribing company Augmedix in July 2024. A banner on the Engage page cites a $70M raise at a $7B valuation for Commure.

Fierce Healthcare later updated its coverage to report that Edward Elmhurst Health was no longer a Memora customer and that the former CEO, Manav Sevak, had left.

What does Engage automate?

The Engage page lists three product areas. AI call center agents handle scheduling, confirmation, rescheduling, call routing and after-hours coverage. Referral management reaches out to referred patients and follows up with those who do not respond. Care pathways cover pre-procedure preparation, post-discharge symptom monitoring, chronic disease, maternal health and behavioral health.

The vendor says the pathways number "more than 500," authored and maintained by clinical experts. Patients can reply by SMS, RCS, voice or email without installing an app, and two-way messages go through triage rules that escalate to staff. Remote monitoring supports blood pressure cuffs, scales and glucose monitors.

The page describes the AI as retrieval-based and says Engage "uses validated clinical content and deterministic logic to deliver safe, reliable responses, never hallucinated outputs."

On integrations, the page promises bi-directional connection with "all major EHRs" and says the wider Commure platform is integrated with more than 60 of them. It names no EHR. Commure's HIPAA and SOC 2 claims appear on its scribe pages and cover the scribe product.

Where do the outcome numbers come from?

The Engage page reports 80% or more of inquiries resolved automatically, 54% fewer no-shows and 16% fewer readmissions. All three are the vendor's figures, published without a method. The Mount Sinai and Yale New Haven case studies on the page are vendor-authored. Outside coverage concerns the acquisition, including the customer departure Fierce noted.

How is Engage sold?

Engage is quote only, and the page's call to action reads "Get in touch."

The verdict

Engage fits a health system or large group that wants automated scheduling calls, referral follow-up and discharge outreach and is ready to request a quote. The 80%, 54% and 16% figures are the vendor's own, and Fierce reported a customer departure after the acquisition. An independent practice with a front desk and a patient portal should not buy it.